Registry-based research makes it possible for clinical research to be faster and cheaper. Particularly when studying patient populations that are especially hard to recruit, for example, heart failure patients with comorbidities. The Dutch Heart Foundation and the Rational Pharmacotherapy Program of ZonMw are investing in the development of a sustainable infrastructure for registry-based research, facilitated by the Dutch CardioVascular Alliance (DCVA).
The Dutch Heart Foundation and ZonMw appointed two initiators to form a national consortium on registry-based research, in which relevant partners within the DCVA can participate. These initiators will also coordinate the procedure for research application.
- dr. Dennis van Veghel, director of the Netherlands Heart Registration;
- prof. dr. Folkert W. Asselbergs, professor of cardiology, UMC Utrecht.
Brought to the patient more rapidly
Folkert Asselbergs, initiator of the consortium: "Registry-based research does not only give the possibility to evaluate our current healthcare longitudinally but also gives us the possibility to optimise the execution of randomised research within routine care. Healthcare innovations will be brought to the patient more rapidly, due to the fact that healthcare providers and researchers can evaluate various treatment strategies in relevant patient groups more efficiently and at a lower cost."
Development and testing
Besides developing the infrastructure, the consortium will also conduct several research projects to test its success. These projects are thematically related to improved treatment of patients suffering from heart failure.
Combining and connecting the expertise
Dennis van Veghel, initiator of the consortium: "Through combining and connecting the expertise and experience of the various partners of the DCVA, we can shape an infrastructure for registry-based research. We ensure that quality registrations are well embedded in electronic patient files so that the registration burden remains limited. In this way, we pave the way for new forms of research such as registration-based clinical trials. Based on real world data, we contribute to new insights to further improve patient care."
Want to join the new consortium?
Are you involved in registration-based research or are you conducting clinical research in the field of heart failure treatments? Do you want to join this new consortium? Read the conditions in the brochure and contact the initiators. The deadline is May 18, 2021.
Download the brochure
Interessant voor jou
Open PPS-programmaPubliek-private samenwerkingen zorgen dat resultaten van onderzoek terechtkomen bij patiënten.
Dutch CardioVascular Alliance (DCVA)Met hulp van de DCVA vertalen we onderzoeksresultaten zo snel mogelijk in een verbetering van het dagelijks leven van patiënten.
- Onze missie
Goed onderzoekDe Hartstichting investeert in goed wetenschappelijk onderzoek dat bijdraagt aan onze ambitie: een steeds lagere ziektelast.